Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Abasaglar ® (basal insulin glargine)
This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
Abasaglar® (insulin glargine): How use the KwikPen
Abasaglar KwikPen is a prefilled disposable pen containing 300 units (3 mL) of insulin glargine.
Instruction for Use
KwikPen Device
Abasaglar is available as a 3-mL prefilled disposable pen (KwikPen®) containing 300 units (100 units/mL) of insulin glargine (Abasaglar® KwikPen®).1,2
Priming ensures the pen is ready to dose and removes air that may collect in the needle and cartridge during normal use. If the pen is not primed before each injection, the patient may get too much or too little insulin.2
A new needle must be used for each injection to help prevent infection and obstructed needles.2
The pen dials 1 unit at a time. 1 to 80 insulin units may be administered from a single injection of the pen.
If the prescribed dose is more than 80 units, the patient will need more than one injection. 2
The pen can only be dialled up to the amount of insulin units remaining in the pen. If the dose exceeds the number of insulin units left in the pen, the patient may
- inject the amount left in the pen and then use a new pen to give the rest of the dose, or
- get a new pen and inject the full dose.
A small amount of insulin will remain in the pen that cannot be injected.2
KwikPen: Safe Use
The patient should not use the pen if any part looks broken or damaged.2
If the pen cap is unable to be removed, the patient should gently twist the cap back and forth and then pull the cap straight off. 2
If the dose knob it is hard to push:3
- Pushing the dose knob more slowly will make it easier to inject.
- Your needle may be blocked. Put on a new needle and prime the pen.
- You may have dust, food, or liquid inside the pen. Throw the pen away and get a new pen.
To prevent the spread of infections, the pen must never be shared between patients even if the needle is changed.2
Patients who are blind or visually impaired should not use the pen without help from someone who is properly trained.2
References
1Abasaglar [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
2Abasaglar [instructions for use]. Eli Lilly Nederland B.V., The Netherlands .
3Abasaglar 100 units/mL KwikPen [instructions for use]. Eli Lilly Nederland B.V., The Netherlands.
Glossary
Abasaglar = Abasaglar® (insulin glargine) 100 units/mL
Pen = KwikPen®
Date of Last Review: 12 February 2024